Center for the Study of Metabolic and Liver Diseases, Department of Internal Medicine, Università degli Studi Milano, Internal Medicine 1B, Hospital Fondazione Policlinico MaRE IRCCS, Milano, Italy.
Nutr Metab Cardiovasc Dis. 2011 Aug;21(8):568-75. doi: 10.1016/j.numecd.2010.01.003. Epub 2010 Apr 13.
Increased ferritin and body iron stores are frequently observed in nonalcoholic fatty liver disease (NAFLD), associated with heightened susceptibility to vascular damage. Conflicting data have been reported on the role of iron in atherosclerosis, with recent data suggesting that excess iron induces vascular damage by increasing levels of the hormone hepcidin, which would determine iron trapping into macrophages, oxidative stress, and promotion of transformation into foam cells. Aim of this study was to investigate the relationship between iron status and cardiovascular damage in NAFLD.
Vascular damage was evaluated by common carotid arteries intima-media thickness (CC-IMT) measurement and plaque detection by ecocolor-doppler ultrasonography in 506 patients with clinical and ultrasonographic diagnosis of NAFLD, hemochromatosis gene (HFE) mutations by restriction analysis in 342 patients. Serum hepcidin-25 was measured by time-of-flight mass spectrometry in 143 patients. At multivariate analysis CC-IMT was associated with systolic blood pressure, glucose, LDL cholesterol, abdominal circumference, age, and ferritin (p=0.048). Carotid plaques were independently associated with age, ferritin, glucose, and hypertension. Ferritin reflected iron stores and metabolic syndrome components, but not inflammation or liver damage. Hyperferritinemia was associated with increased vascular damage only in patients with HFE genotypes associated with hepcidin upregulation by iron stores (p<0.0001), and serum hepcidin-25 was independently associated with carotid plaques (p=0.05).
Ferritin levels, reflecting iron stores, are independent predictors of vascular damage in NAFLD. The mechanism may involve upregulation of hepcidin by increased iron stores in patients not carrying HFE mutations, and iron compartmentalization into macrophages.
非酒精性脂肪性肝病(NAFLD)常伴有铁蛋白和体内铁储存增加,易发生血管损伤。关于铁在动脉粥样硬化中的作用,目前存在相互矛盾的数据,最近的数据表明,过量的铁通过增加激素铁调素的水平来诱导血管损伤,从而导致铁捕获到巨噬细胞、氧化应激和促进泡沫细胞转化。本研究旨在探讨 NAFLD 中铁状态与心血管损伤的关系。
通过常规颈动脉内膜中层厚度(CC-IMT)测量和超声彩色多普勒检测评估血管损伤,在 506 例临床和超声诊断为 NAFLD 的患者中进行,在 342 例患者中通过限制分析检测血色病基因(HFE)突变。在 143 例患者中通过飞行时间质谱法测量血清铁调素-25。多变量分析显示,CC-IMT 与收缩压、血糖、LDL 胆固醇、腹围、年龄和铁蛋白相关(p=0.048)。颈动脉斑块与年龄、铁蛋白、血糖和高血压独立相关。铁蛋白反映铁储存和代谢综合征成分,但不反映炎症或肝损伤。高铁蛋白血症仅与 HFE 基因型相关,这些基因型与铁储存引起的铁调素上调有关(p<0.0001),与血管损伤增加相关,且血清铁调素-25 与颈动脉斑块独立相关(p=0.05)。
铁蛋白水平反映铁储存,是 NAFLD 血管损伤的独立预测因子。其机制可能涉及到不携带 HFE 突变的患者中,铁储存增加引起铁调素上调,以及铁向巨噬细胞的分隔。